Eye movements in patients with neurodegenerative disorders

Nature Reviews Neurology

Volumn 9, Issue 2, 2013, Pages 74-85

  Anderson, Tim J ^a   MacAskill, Michael R ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NEW ZEALAND BRAIN RESEARCH INSTITUTE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APRAXIA; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DYSMETRIA; EYE MOVEMENT CONTROL; EYE MOVEMENT DISORDER; FRONTOTEMPORAL DEMENTIA; GAZE PARALYSIS; HUMAN; HUNTINGTON CHOREA; LATENT PERIOD; MILD COGNITIVE IMPAIRMENT; MOTOR NEURON DISEASE; NYSTAGMUS; OPHTHALMOPLEGIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SACCADIC EYE MOVEMENT; SHY DRAGER SYNDROME; SMOOTH PURSUIT EYE MOVEMENT; SPINOCEREBELLAR DEGENERATION; VESTIBULOOCULAR REFLEX;

BASAL GANGLIA DISEASES; BIOLOGICAL MARKERS; DEMENTIA; EYE MOVEMENTS; HUMANS; HUNTINGTON DISEASE; LEWY BODY DISEASE; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; PSYCHOMOTOR PERFORMANCE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84873706898     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.273     Document Type: Review

References (117)

1. Bridgeman, B. Conscious vs unconscious processes: the case of vision. Theory Psychology 2, 73-88 (1992).
2. Deubel, H. & Schneider, W. X. Delayed saccades, but not delayed manual aiming movements, require visual attention shifts. Ann. NY Acad. Sci. 1004, 289-296 (2003). (Pubitemid 38496592)
3. Aarsland, D. in Cognitive Impairment and Dementia in Parkinson's Disease (ed. Emre, M.) 5-14 (Oxford University Press, Oxford, 2010).
4. Anderson, T. et al. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov. Disord. 23, 977-984 (2008).
5. Chen, A. L. et al. The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front. Neurol. 1, 147 (2010).
6. Hellmuth, J. et al. Multicenter validation of a bedside antisaccade task as a measure of executive function. Neurology 78, 1824-1831 (2012).
7. Garbutt, S. et al. Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. Brain 131, 1268-1281 (2008).
8. Tabrizi, S. J. et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 8, 791-801 (2009).
9. Tabrizi, S. J. et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 11, 42-53 (2012).
10. Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 10, 31-42 (2011).
11. Munoz, D. P., Dorris, M. C., Pare, M. & Everling, S. On your mark, get set: brainstem circuitryunderlying saccadic initiation. Can. J. Physiol. Pharmacol. 78, 934-944 (2000).
12. Deubel, H. in Attention and Performance XVII: Cognitive Regulation of Performance (eds Gopher, D. & Koriat, A.) 697-721 (MIT Press, Cambridge, MA, 1999).
13. Liu, P. & Basso, M. A. Substantia nigra stimulation influences monkey superior colliculus neuronal activity bilaterally. J. Neurophysiol. 100, 1098-1112 (2008).
14. Terao, Y. et al. Initiation and inhibitory control of saccades with the progression of Parkinson's disease - changes in three major drives converging on the superior colliculus. Neuropsychologia 49, 1794-1806 (2011).
15. MacAskill, M. R. et al. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease. Neuropsychologia 50, 3338-3347 (2012).
16. Bronstein, A. M. & Kennard, C. Predictive ocular motor control in Parkinson's disease. Brain 108, 925-940 (1985). (Pubitemid 16185409)
17. Crawford, T. J., Goodrich, S., Henderson, L. & Kennard, C. Predictive responses in Parkinson's disease: manual keypresses and saccadic eye movements to regular stimulus events. J. Neurol. Neurosurg. Psychiatry 52, 1033-1042 (1989). (Pubitemid 19232781)
18. Ventre, J., Zee, D. S., Papageorgiou, H. & Reich, S. Abnormalities of predictive saccades in hemi-Parkinson's disease. Brain 115, 1147-1165 (1992).
19. O'Sullivan, S. S. et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131, 1362-1372 (2008).
20. Chambers, J. M. & Prescott, T. J. Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review. Neuropsychologia 48, 887-899 (2010).
21. Mosimann, U. P. et al. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 128, 1267-1276 (2005). (Pubitemid 40826181)
22. Matsumoto, H. et al. Small saccades restrict visual scanning area in Parkinson's disease. Mov. Disord. 26, 1619-1626 (2011).
23. Clark, U. S., Neargarder, S. & Cronin-Golomb, A. Visual exploration of emotional facial expressions in Parkinson's disease. Neuropsychologia 48, 1901-1913 (2010).
24. Anastasopoulos, D., Ziavra, N., Savvidou, E., Bain, P. & Bronstein, A. M. Altered eye to foot coordination in standing parkinsonian patients during large gaze and whole-body reorientations. Mov. Disord. 26, 2201-2211 (2011).
25. Carpenter, M. G. & Bloem, B. R. A new twist on turning movements in Parkinson's disease patients. Mov. Disord. 26, 2151-2153 (2011).
26. Lohnes, C. A. & Earhart, G. M. Saccadic eye movements are related to turning performance in Parkinson disease. J. Parkinsons Dis. 1, 109-118 (2011).
27. Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837-844 (2008).
28. Pinkhardt, E. H. et al. Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms. BMC Neurol. 12, 5 (2012).
29. van Stockum, S., MacAskill, M. R., Anderson, T. J. & Dalrymple-Alford, J. C. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease? Neuropsychologia 46, 3108-3115 (2008).
30. Perneczky, R. et al. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. Neurobiol. Dis. 43, 79-85 (2011).
31. Nakashima, H. et al. An autopsied case of dementia with Lewy bodies with supranuclear gaze palsy. Neurol. Res. 25, 533-537 (2003). (Pubitemid 36870538)
32. Kapoula, Z. et al. Spread deficits in initiation, speed and accuracy of horizontal and vertical automatic saccades in dementia with lewy bodies. Front. Neurol. 1, 138 (2010).
33. Gilman, S. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670-676 (2008).
34. Rascol, O. et al. Square wave jerks in parkinsonian syndromes. J. Neurol. Neurosurg. Psychiatry 54, 599-602 (1991).
35. Linder, J., Wenngren, B. I., Stenlund, H. & Forsgren, L. Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism. J. Neurol. 259, 1206-1214 (2012).
36. Rascol, O. et al. Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. Brain 112, 1193-1214 (1989). (Pubitemid 19246373)
37. Stell, R. & Bronstein, A. M. in Movement Disorders 3 (eds Marsden, C. D. & Fahn, S.) 88-113 (Butterworth-Heinemann Ltd, Oxford, 1994).
38. Arpa, J. et al. Electro-oculogram in multiple system and late onset cerebellar atrophies. Rev. Neurol. 23, 969-974 (1995).
39. Rascol, O. J., Clanet, M., Senard, J. M., Montastruc, J. L. & Rascol, A. Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy. Adv. Neurol. 60, 395-397 (1993).
40. Lee, J. Y. et al. Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov. Disord. 24, 1290-1295 (2009).
41. Williams, D. R. et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247-1258 (2005). (Pubitemid 40826179)
42. Williams, D. R., Holton, J. L., Strand, K., Revesz, T. & Lees, A. J. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov. Disord. 22, 2235-2241 (2007).
43. Williams, D. R. & Lees, A. J. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 8, 270-279 (2009).
44. Troost, B. T. & Daroff, R. B. The ocular motor defects in progressive supranuclear palsy. Ann. Neurol. 2, 397-403 (1977). (Pubitemid 8400439)
45. Bhidayasiri, R. et al. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 57, 2070-2077 (2001). (Pubitemid 33126876)
46. Vidailhet, M. et al. Eye movements in parkinsonian syndromes. Ann. Neurol. 35, 420-426 (1994).
47. Rivaud-Pechoux, S. et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54, 1029-1032 (2000). (Pubitemid 30151841)
48. Boxer, A. L. et al. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Arch. Neurol. 69, 509-517 (2012).
49. Litvan, I. et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele Richardson Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47, 1-9 (1996). (Pubitemid 26243849)
50. Garbutt, S. et al. Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 75, 1386-1394 (2004). (Pubitemid 39279803)
51. Steele, J. C. Progressive supranuclear palsy. Brain 95, 693-704 (1972).
52. Altiparmak, U. E., Eggenberger, E., Coleman, A. & Condon, K. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease. J. Neuroophthalmol. 26, 257-259 (2006). (Pubitemid 46066878)
53. Rivaud-Pechoux, S., Vidailhet, M., Brandel, J. P. & Gaymard, B. Mixing pro- and antisaccades in patients with parkinsonian syndromes. Brain 130, 256-264 (2007). (Pubitemid 46026240)
54. Vidailhet, M. et al. Saccades and antisaccades in parkinsonian syndromes. Adv. Neurol. 80, 377-382 (1999).
55. Wadia, P. M. & Lang, A. E. The many faces of corticobasal degeneration. Parkinsonism Relat. Disord. 13 (Suppl. 3), S336-S340 (2007). (Pubitemid 351215265)
56. Ling, H. et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133, 2045-2057 (2010).
57. Vidailhet, M. & Rivaud-Pechoux, S. Eye movement disorders in corticobasal degeneration. Adv. Neurol. 82, 161-167 (2000).
58. Rottach, K. G., Riley, D. E., DiScenna, A. O., Zivotofsky, A. Z. & Leigh, R. J. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann. Neurol. 39, 368-377 (1996). (Pubitemid 26100761)
59. Murray, R. et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68, 1274-1283 (2007). (Pubitemid 46625973)
60. Lasker, A. G., Zee, D. S., Hain, T. C., Folstein, S. E. & Singer, H. S. Saccades in Huntington's disease: slowing and dysmetria. Neurology 38, 427-431 (1988). (Pubitemid 18083683)
61. Lasker, A. G. & Zee, D. S. Ocular motor abnormalities in Huntington's disease. Vision Res. 37, 3639-3645 (1997). (Pubitemid 27491640)
62. Peltsch, A., Hoffman, A., Armstrong, I., Pari, G. & Munoz, D. P. Saccadic impairments in Huntington's disease. Exp. Brain Res. 186, 457-469 (2008).
63. Golding, C. V., Danchaivijitr, C., Hodgson, T. L., Tabrizi, S. J. & Kennard, C. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67, 485-487 (2006). (Pubitemid 44214975)
64. Rupp, J. et al. Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease. J. Neurol. 259, 267-276 (2012).
65. Winograd-Gurvich, C. T. et al. Hypometric primary saccades and increased variability in visually-guided saccades in Huntington's disease. Neuropsychologia 41, 1683-1692 (2003). (Pubitemid 36900361)
66. Leigh, R. J., Newman, S. A., Folstein, S. E., Lasker, A. G. & Jensen, B. A. Abnormal ocular motor control in Huntington's disease. Neurology 33, 1268-1275 (1983). (Pubitemid 13021186)
67. Blekher, T. et al. Saccades in presymptomatic and early stages of Huntington disease. Neurology 67, 394-399 (2006). (Pubitemid 44214959)
68. Patel, S. S., Jankovic, J., Hood, A. J., Jeter, C. B. & Sereno, A. B. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J. Neurol. Sci. 313, 35-41 (2012).
69. Henderson, T. et al. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease. Mov. Disord. 26, 1893-1899 (2011).
70. Turner, T. H. et al. Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease. J. Mot. Behav. 43, 295-302 (2011).
71. Hicks, S. L., Robert, M. P., Golding, C. V., Tabrizi, S. J. & Kennard, C. Oculomotor deficits indicate the progression of Huntington's disease. Prog. Brain Res. 171, 555-558 (2008).
72. Rupp, J. et al. Progression in prediagnostic Huntington disease. J. Neurol. Neurosurg. Psychiatry 81, 379-384 (2010).
73. Rupp, J. et al. Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease. Neuropsychology 25, 306-318 (2011).
74. Antoniades, C. A., Xu, Z., Mason, S. L., Carpenter, R. H. & Barker, R. A. Huntington's disease: changes in saccades and hand-tapping over 3 years. J. Neurol. 257, 1890-1898 (2010).
75. Josephs, K. A. Frontotemporal dementia and related disorders: deciphering the enigma. Ann. Neurol. 64, 4-14 (2008).
76. Burrell, J. R., Hornberger, M., Carpenter, R. H., Kiernan, M. C. & Hodges, J. R. Saccadic abnormalities in frontotemporal dementia. Neurology 78, 1816-1823 (2012).
77. Currie, J., Ramsden, B., McArthur, C. & Maruff, P. Validation of a clinical antisaccadic eye movement test in the assessment of dementia. Arch. Neurol. 48, 644-648 (1991).
78. Abel, L. A., Unverzagt, F. & Yee, R. D. Effects of stimulus predictability and interstimulus gap on saccades in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 13, 235-243 (2002). (Pubitemid 34507609)
79. Boxer, A. L. et al. Medial versus lateral frontal lobe contributions to voluntary saccade control as revealed by the study of patients with frontal lobe degeneration. J. Neurosci. 26, 6354-6363 (2006).
80. Crawford, T. J. et al. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease. Biol. Psychiatry 57, 1052-1060 (2005). (Pubitemid 40603088)
81. Shafiq-Antonacci, R., Maruff, P., Masters, C. & Currie, J. Spectrum of saccade system function in Alzheimer disease. Arch. Neurol. 60, 1272-1278 (2003). (Pubitemid 37099635)
82. Fletcher, W. A. & Sharpe, J. A. Saccadic eye movement dysfunction in Alzheimer's disease. Ann. Neurol. 20, 464-741 (1986).
83. Yang, Q., Wang, T., Su, N., Xiao, S. & Kapoula, Z. Specific saccade deficits in patients with Alzheimer's disease at mild to moderate stage and in patients with amnestic mild cognitive impairment. Age (Dordr.) http://dx.doi.org/10.1007/s11357 012 9420 z.
84. Yang, Q. et al. Long latency and high variability in accuracy-speed of prosaccades in Alzheimer's disease at mild to moderate stage. Dement. Geriatr. Cogn. Dis. Extra 1, 318-329 (2011).
85. Schewe, H. J., Uebelhack, R. & Vohs, K. Abnormality in saccadic eye movement in dementia. Eur. Psychiatry 14, 52-53 (1999).
86. Donaghy, C. et al. Slow saccades in bulbar-onset motor neurone disease. J. Neurol. 257, 1134-1140 (2010).
87. Donaghy, C., Thurtell, M. J., Pioro, E. P., Gibson, J. M. & Leigh, R. J. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J. Neurol. Neurosurg. Psychiatry 82, 110-116 (2011).
88. Ohki, M. et al. Ocular abnormalities in amyotrophic lateral sclerosis. Acta Otolaryngol. Suppl. 511, 138-142 (1994). (Pubitemid 24104614)
89. Averbuch-Heller, L., Helmchen, C., Horn, A. K., Leigh, R. J. & Buttner-Ennerver, J. A. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann. Neurol. 44, 641-648 (1998). (Pubitemid 28477852)
90. Leveille, A., Kiernan, J., Goodwin, J. A. & Antel, J. Eye movements in amyotrophic lateral sclerosis. Arch. Neurol. 39, 684-686 (1982). (Pubitemid 12003421)
91. McCluskey, L. F. et al. Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein 43 pathology. Arch. Neurol. 66, 121-124 (2009).
92. Shaunak, S. et al. Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann. Neurol. 38, 38-44 (1995).
93. Donaghy, C. et al. Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction? J. Neurol. 256, 420-426 (2009).
94. Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575-621 (2007). (Pubitemid 47218768)
95. Yabe, I. et al. Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6). J. Neurol. 250, 440-443 (2003). (Pubitemid 36459750)
96. Gomez, C. M. et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann. Neurol. 42, 933-950 (1997). (Pubitemid 28008425)
97. Buttner, N. et al. Oculomotor phenotypes in autosomal dominant ataxias. Arch. Neurol. 55, 1353-1357 (1998).
98. Bour, L. J., van Rootselaar, A. F., Koelman, J. H. & Tijssen, M. A. Oculomotor abnormalities in myoclonic tremor: a comparison with spinocerebellar ataxia type 6. Brain 131, 2295-2303 (2008).
99. Marelli, C. et al. SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia. Arch. Neurol. 68, 637-643 (2011).
100. Velazquez-Perez, L. et al. Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann. Neurol. 56, 444-447 (2004). (Pubitemid 39166568)
101. Wadia, N. et al. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis. Brain 121, 2341-2355 (1998). (Pubitemid 28552471)
102. Geiner, S., Horn, A. K., Wadia, N. H., Sakai, H. & Buttner-Ennever, J. A. The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog. Brain Res. 171, 575-581 (2008).
103. Fahey, M. C. et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain 131, 1035-1045 (2008). (Pubitemid 351499415)
104. Burk, K. et al. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J. Neurol. 246, 789-797 (1999). (Pubitemid 29467154)
105. Hubner, J. et al. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17). Neurology 69, 1160-1168 (2007). (Pubitemid 47517562)
106. Enevoldson, T. P., Sanders, M. D. & Harding, A. E. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain 117, 445-460 (1994).
107. Oh, A. K., Jacobson, K. M., Jen, J. C. & Baloh, R. W. Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7. Ann. Neurol. 49, 801-804 (2001). (Pubitemid 32530249)
108. Thurtell, M. J. et al. Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings. J. Neuroophthalmol. 29, 187-191 (2009).
109. Velazquez-Perez, L. et al. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clin. Neurophysiol. 120, 632-635 (2009).
110. Iacono, W. G. & Lykken, D. T. Two-year retest stability of eye tracking performance and a comparison of electro-oculographic and infrared recording techniques: evidence of EEG in the electro-oculogram. Psychophysiology 18, 49-55 (1981). (Pubitemid 11188705)
111. Roy-Byrne, P., Radant, A., Wingerson, D. & Cowley, D. S. Human oculomotor function: reliability and diurnal variation. Biol. Psychiatry 38, 92-97 (1995).
112. Blekher, T. et al. Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest. Ophthalmol. Vis. Sci. 50, 5707-5711 (2009).
113. Rivaud-Péchoux, S. et al. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry 68, 381-384 (2000). (Pubitemid 30248719)
114. Sauleau, P. et al. Subthalamic stimulation improves orienting gaze movements in Parkinson's disease. Clin. Neurophysiol. 119, 1857-1863 (2008).
115. Temel, Y., Visser-Vandewalle, V. & Carpenter, R. H. Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease. Exp. Neurol. 216, 481-489 (2009).
116. Temel, Y., Visser-Vandewalle, V. & Carpenter, C. Saccadic latency during electrical stimulation of the human subthalamic nucleus. Curr. Biol. 18, R412-R414 (2008). (Pubitemid 351672027)
117. Pinkhardt, E. H. & Kassubek, J. Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat. Disord. 17, 223-230 (2011).